Haematologica, Vol 92, Issue 3, 425-426 doi:10.3324/haematol.10800
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Couillard, S.
Right arrow Articles by Bader-Meunier, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couillard, S.
Right arrow Articles by Bader-Meunier, B.

Red Cell Disorders

Steroid treatment in children with sickle-cell disease

Sonia Couillard*, Malika Benkerrou°, Robert Girot#, Valentine Brousse@, Alicia Ferster^, Brigitte Bader-Meunier*,

* Service de Pédiatrie générale, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
° Service d’Hématologie pédiatrique, Hôpital Robert Debré, Paris, France;
# Service d’Hématologie, Hôpital Tenon, Paris, France
@ Service de Pédiatrie générale, Hôpital Necker, Paris, France
^ Département d’ Hématologie/Oncologie, Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgium

Correspondence: Brigitte Bader-Meunier, Service d’Hématologie pédiatrique, Hôpital Robert Debré, Bd Serrurier, 75019 Paris, France. E-mail: brigitte.bader-meunier{at}rdb.ap-hop-paris.fr

Given the controversy concerning the effects of steroids in patients with sickle cell disease (SCD), we evaluated the tolerability of long-term steroid treatment in 16 children with SCD and autoimmune and/or systemic diseases. The steroid treatment was poorly tolerated.




This article has been cited by other articles:


Home page
 BloodHome page
P. Bartolucci, T. El Murr, F. Roudot-Thoraval, A. Habibi, A. Santin, B. Renaud, V. Noel, M. Michel, D. Bachir, F. Galacteros, et al.
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
Blood, October 29, 2009; 114(18): 3742 - 3747.
[Abstract] [Full Text] [PDF]